One key player during this adaptive response to low oxygen is hypoxia-inducible factor-1 (HIF-1), a transcription factor that accumulates and delivers O2 to tumor cells during hypoxia via enhancing angiogenesis, erythropoiesis, and rapid glycolysis, allowing cancer cells to thrive even under physiological stress [14,15,16]. This evidence concerns the gene HIF1A and cancer.